Vivesto AB (OASMY) Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise Transcript
Source: SeekingAlpha
2025-11-24 18:13:45 ET
Vivesto AB (OASMY) Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise November 24, 2025 9:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Vivesto AB (OASMY) Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise Transcript
Oasmia Pharmaceutical AB - ADR
NASDAQ: OASMY
OASMY Trading
0.0% G/L:
$0.0001 Last:
1,000 Volume:
$0.0001 Open:
